HRP20040486A2 - Controlled release polymeric compositions of bone growth promoting compounds - Google Patents

Controlled release polymeric compositions of bone growth promoting compounds Download PDF

Info

Publication number
HRP20040486A2
HRP20040486A2 HR20040486A HRP20040486A HRP20040486A2 HR P20040486 A2 HRP20040486 A2 HR P20040486A2 HR 20040486 A HR20040486 A HR 20040486A HR P20040486 A HRP20040486 A HR P20040486A HR P20040486 A2 HRP20040486 A2 HR P20040486A2
Authority
HR
Croatia
Prior art keywords
compound
polymer
approximately
methyl
butylbenzyl
Prior art date
Application number
HR20040486A
Other languages
English (en)
Croatian (hr)
Inventor
Francis Dumont
Richard
Mei Li
Vishwas Madhav Paralkar
Richad Lee Dunn
Scott Alexander Jeffers
Mingxing Zhou
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP20040486A2 publication Critical patent/HRP20040486A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
HR20040486A 2001-11-30 2002-11-20 Controlled release polymeric compositions of bone growth promoting compounds HRP20040486A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33725501P 2001-11-30 2001-11-30
PCT/IB2002/004965 WO2003045351A1 (fr) 2001-11-30 2002-11-20 Compositions polymeres a liberation controlee de composes stimulant la formation osseuse

Publications (1)

Publication Number Publication Date
HRP20040486A2 true HRP20040486A2 (en) 2004-10-31

Family

ID=23319774

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040486A HRP20040486A2 (en) 2001-11-30 2002-11-20 Controlled release polymeric compositions of bone growth promoting compounds

Country Status (35)

Country Link
US (2) US20030104031A1 (fr)
EP (1) EP1448166A1 (fr)
JP (1) JP4903985B2 (fr)
KR (1) KR100629380B1 (fr)
CN (1) CN1599598A (fr)
AP (1) AP1781A (fr)
AR (1) AR037462A1 (fr)
AU (2) AU2002347502A1 (fr)
BR (1) BR0214610A (fr)
CA (1) CA2468703C (fr)
DO (1) DOP2002000534A (fr)
EA (1) EA011350B1 (fr)
EC (1) ECSP045124A (fr)
GE (1) GEP20063951B (fr)
GT (1) GT200200242A (fr)
HR (1) HRP20040486A2 (fr)
HU (1) HUP0402135A3 (fr)
IL (1) IL161835A0 (fr)
IS (1) IS7217A (fr)
MA (1) MA27084A1 (fr)
MX (1) MXPA04003723A (fr)
NO (1) NO20042273L (fr)
NZ (1) NZ533115A (fr)
OA (1) OA12731A (fr)
PA (1) PA8559001A1 (fr)
PE (1) PE20030581A1 (fr)
PL (1) PL370085A1 (fr)
PY (1) PY0229226A (fr)
SV (1) SV2004001421A (fr)
TN (1) TNSN04096A1 (fr)
TW (1) TW200300695A (fr)
UA (1) UA76792C2 (fr)
WO (1) WO2003045351A1 (fr)
YU (1) YU35004A (fr)
ZA (1) ZA200402755B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074425B2 (en) * 2002-09-26 2006-07-11 Bonewax, Llc Hemostatic compositions and methods
EP1596765A2 (fr) * 2003-02-10 2005-11-23 Smith & Nephew, Inc. Dispositifs resorbables
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8641738B1 (en) 2004-10-28 2014-02-04 James W. Ogilvie Method of treating scoliosis using a biological implant
US8123787B2 (en) 2004-10-28 2012-02-28 Ogilvie James W Method of treating scoliosis using a biological implant
JP2009504929A (ja) * 2005-08-18 2009-02-05 スミス アンド ネフュー ピーエルシー 高強度デバイス及び複合材料
CN100443065C (zh) * 2006-01-26 2008-12-17 上海交通大学 用于颌面骨缺损修复的复合体系植入体单元
AU2007325001B2 (en) 2006-11-30 2014-04-10 Smith & Nephew, Inc. Fiber reinforced composite material
US9815240B2 (en) 2007-04-18 2017-11-14 Smith & Nephew, Inc. Expansion moulding of shape memory polymers
US9770534B2 (en) 2007-04-19 2017-09-26 Smith & Nephew, Inc. Graft fixation
ATE547129T1 (de) 2007-04-19 2012-03-15 Smith & Nephew Inc Multimodale formgedächtnis-polymere
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
RU2504360C2 (ru) 2008-08-12 2014-01-20 Новартис Аг Фармацевтические композиции
EP2172189A1 (fr) * 2008-10-01 2010-04-07 Novartis AG Compositions pharmaceutiques
US20100130959A1 (en) * 2008-10-15 2010-05-27 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via artificial internal implants
US9642658B2 (en) 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
WO2013043569A1 (fr) 2011-09-20 2013-03-28 Vical Incorporated Immunothérapie combinée à action antitumorale synergique faisant appel à des alloantigènes
CN104189954B (zh) * 2014-09-19 2017-03-29 中国科学院长春应用化学研究所 一种原位固化组织工程支架及其制备方法
RU2571548C1 (ru) * 2014-12-17 2015-12-20 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук Ветеринарное имплантируемое средство пролонгированного действия (варианты)
CA3005313C (fr) 2015-11-16 2024-01-09 Evonik Rohm Gmbh Solution injectable comprenant un inhibiteur de transcriptase inverse non nucleosidique et du poly(lactide-co-glycolide)
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
CN114599372A (zh) 2019-11-04 2022-06-07 阿斯利康(瑞典)有限公司 用于治疗癌症的组合疗法
WO2022144810A1 (fr) 2020-12-29 2022-07-07 Sino Medical Sciences Technology Inc. Endoprothèse à élution de médicament
EP4608390A1 (fr) 2022-10-24 2025-09-03 Cancer Research Technology Limited Sensibilisation tumorale à des inhibiteurs de points de contrôle avec modificateur d'état redox
EP4608995A1 (fr) 2022-10-24 2025-09-03 Memorial Sloan-Kettering Cancer Center Stratification de tumeurs pour déterminer la sensibilité à un inhibiteur de point de contrôle immunitaire
EP4649173A1 (fr) 2023-01-13 2025-11-19 Akrivia Biomedics Limited Procédé de profilage de maladies
NL2037811B1 (en) 2024-05-29 2025-12-12 Univ Oslo Treatment for Cancer
GB202408360D0 (en) 2024-06-11 2024-07-24 Cancer Research Tech Ltd Tumour sensitisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028124A2 (fr) * 1994-04-08 1995-10-26 Atrix Laboratories, Inc. Systeme auxiliaire de polymeres pour dispositif medical
AU4652596A (en) 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
JP4642946B2 (ja) * 1996-12-20 2011-03-02 アルザ コーポレイション ゲル組成物および方法
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
UA67754C2 (uk) * 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Also Published As

Publication number Publication date
HUP0402135A2 (hu) 2005-02-28
JP4903985B2 (ja) 2012-03-28
KR20040062977A (ko) 2004-07-09
MXPA04003723A (es) 2005-04-08
IS7217A (is) 2004-04-07
IL161835A0 (en) 2005-11-20
AU2002347502A1 (en) 2003-06-10
KR100629380B1 (ko) 2006-09-29
PL370085A1 (en) 2005-05-16
JP2005515190A (ja) 2005-05-26
CN1599598A (zh) 2005-03-23
CA2468703C (fr) 2009-12-29
YU35004A (sh) 2006-08-17
EA200400608A1 (ru) 2004-10-28
EA011350B1 (ru) 2009-02-27
CA2468703A1 (fr) 2003-06-05
GEP20063951B (en) 2006-10-25
UA76792C2 (uk) 2006-09-15
ZA200402755B (en) 2005-04-08
AU2009200125A1 (en) 2009-02-05
TNSN04096A1 (fr) 2006-06-01
DOP2002000534A (es) 2003-05-31
US20030104031A1 (en) 2003-06-05
PY0229226A (es) 2004-06-01
OA12731A (en) 2006-06-28
AR037462A1 (es) 2004-11-10
NO20042273L (no) 2004-07-14
NZ533115A (en) 2005-12-23
WO2003045351A1 (fr) 2003-06-05
MA27084A1 (fr) 2004-12-20
BR0214610A (pt) 2004-09-14
US8017144B2 (en) 2011-09-13
SV2004001421A (es) 2004-05-07
TW200300695A (en) 2003-06-16
HUP0402135A3 (en) 2008-04-28
AU2009200125B2 (en) 2012-02-02
ECSP045124A (es) 2004-07-23
EP1448166A1 (fr) 2004-08-25
US20090169595A1 (en) 2009-07-02
PA8559001A1 (es) 2003-11-12
PE20030581A1 (es) 2003-07-08
GT200200242A (es) 2003-06-25
AP1781A (en) 2007-09-27
AP2004003037A0 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
US8017144B2 (en) Controlled release polymeric compositions of bone growth promoting compounds
EP0608313B1 (fr) Formulations de caillot de sang-matrice polymere d'apport de proteines osteogenes
JP5878477B2 (ja) 骨の治癒を加速するためのバナジウム化合物の使用
JP6214548B2 (ja) 骨再生のための治療補助薬としてのインスリン−疑似剤
RU2360663C1 (ru) Гель для регенерации костной ткани
CN111973797A (zh) 一种骨科用无创植入高黏度胶材料及其制备方法及应用
RU2155049C1 (ru) Композиция для костной пластики
US12214105B2 (en) Long lasting biodegradable polymer based in-situ forming implant for treatment of bone injuries
AU2011205741B2 (en) Use of vanadium compounds to accelerate bone healing
US20180318344A1 (en) Zinc or manganese compounds as therapeutic adjuncts for cartilage regeneration and repair
HK1071065A (en) Controlled release polymeric compositions of bone growth promoting compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20071018

Year of fee payment: 6

OBST Application withdrawn